TCRT December 2011

category image Volume 10
No.6 (505-634)
December 2011
ISSN 1533-0338
Open Access
Intensity Modulated Radio Therapy

Improved Normal Tissue Sparing in Head and Neck Radiotherapy Using Biological Cost Function Based-IMRT (575-583)

Intensity-modulated radiotherapy (IMRT) has reduced the impact of acute and late toxicities associated with head and neck radiotherapy. Treatment planning system (TPS) advances in biological cost function based optimization (BBO) and improved segmentation techniques have increased organ at risk (OAR) sparing compared to conventional dose-based optimization (DBO). A planning study was undertaken to compare OAR avoidance in DBO and BBO treatment planning. Simultaneous integrated boost treatment plans were produced for 10 head and neck patients using both planning systems. Plans were compared for tar get coverage and OAR avoidance. Comparisons were made using the BBO TPS Monte Carlo dose engine to eliminate differences due to inherent algorithms. Target coverage (V95%) was maintained for both solutions. BBO produced lower OAR doses, with statistically significant improvement to left (12.3%, p = 0.005) and right parotid mean dose (16.9%, p = 0.004), larynx V50 Gy (71.0%, p = 0.005), spinal cord (21.9%, p < 0.001) and brain stem dose maximums (31.5%, p = 0.002). This study observed improved OAR avoidance with BBO planning. Further investigations will be undertaken to review any clinical benefit of this improved planned dosimetry.

Key words: Biological cost functions; Dose avoidance; Head and neck cancer; Intensity-modulated radiotherapy (IMRT); Monte Carlo algorithms.

This article can be cited as:
N. Anderson, BAppSc, C. Lawford, MSc, V. Khoo, MD, M. Rolfo, DipAppSc, D. Lim Joon, FRANZCR, M. Wada, FRANZCR Improved Normal Tissue Sparing in Head and Neck Radiotherapy Using Biological Cost Function Based-IMRT Technol Cancer Res Treat. 10, 575-583 (2011).

N. Anderson, BAppSc1*
C. Lawford, MSc1
V. Khoo, MD1-3
M. Rolfo, DipAppSc1
D. Lim Joon, FRANZCR1
M. Wada, FRANZCR1

1Department of Radiation Oncology, Austin Health, Heidelberg Heights, Victoria, Australia
2Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Chelsea, London, UK
3University of Melbourne, Victoria, Australia

nigel.anderson@austin.org.au

Open Access Article
The authors, the publisher, and the right holders grant the right to use, reproduce, and disseminate the work in digital form to all users.



Click here to download PDF.


Member Login | Home | Editorial Board | Instructions | Subscribe | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.